EUVIMEDEUVIMED entdecken
Crossref

Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan

Ryo Takahashi, Hiroki Osumi, Takeru Wakatsuki, Noriko Yamamoto, Senzo Taguchi, Izuma Nakayama, Akira Ooki, Mariko Ogura, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Eiji Shinozaki

International Journal of Clinical Oncology · 2024-08 · 29 (8) · 1161-1172

DOI: 10.1007/s10147-024-02540-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 31.05.2024. Verfasst von Ryo Takahashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan. Hauptthemen laut MEDLINE: Anus Neoplasms, Chemoradiotherapy, Carcinoma, Squamous Cell, B7-H1 Antigen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anus NeoplasmsChemoradiotherapyCarcinoma, Squamous CellB7-H1 AntigenHumansMaleFemaleMiddle AgedAgedJapanPrognosisAdultFluorouracilMitomycinDisease-Free SurvivalAged, 80 and overTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsCyclin-Dependent Kinase Inhibitor p16Retrospective StudiesNeoplasm Recurrence, Local

Stichwörter der Autor:innen

Anal squamous cell carcinomaChemoradiotherapyHuman papillomavirusProgrammed cell death ligand 1p16

Substanzen

B7-H1 AntigenCD274 protein, humanFluorouracilMitomycinCyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.
  • Department of General Surgery, Heiman Municipal Hospital, Aichi, Japan.
  • Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan. takeru.wakatsuki@jfcr.or.jp.
  • Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Radiation Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Zitieren

APA

Takahashi, R., Osumi, H., Wakatsuki, T., Yamamoto, N., Taguchi, S., Nakayama, I., Ooki, A., Ogura, M., Takahari, D., Chin, K., Yamaguchi, K., & Shinozaki, E. (2024). Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan. International Journal of Clinical Oncology, 29(8), 1161-1172. https://doi.org/10.1007/s10147-024-02540-0

Vancouver

Takahashi R, Osumi H, Wakatsuki T, Yamamoto N, Taguchi S, Nakayama I, et al. Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan. International Journal of Clinical Oncology. 2024;29(8):1161-1172. doi:10.1007/s10147-024-02540-0

BibTeX
@article{Takahashi2024,
  author = {Takahashi, Ryo and Osumi, Hiroki and Wakatsuki, Takeru and Yamamoto, Noriko and Taguchi, Senzo and Nakayama, Izuma and Ooki, Akira and Ogura, Mariko and Takahari, Daisuke and Chin, Keisho and Yamaguchi, Kensei and Shinozaki, Eiji},
  title = {Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  volume = {29},
  number = {8},
  pages = {1161--1172},
  doi = {10.1007/s10147-024-02540-0}
}
Kostenlos starten →